What is Oglethorpe Ear , Nose & Throat?
Oglethorpe Ear, Nose & Throat operates as a specialized medical practice focused on the diagnosis and treatment of ear, nose, throat, and respiratory conditions. Serving patients across all age demographics, the practice has established a reputation for accessibility, notably through its same-day appointment model. Under the leadership of Dr. Robert B. Pitts, the firm has maintained a legacy of patient-centric care spanning over four decades. The current market position is defined by a strategic transition phase, as the practice manages the orderly retirement of its lead physician while ensuring rigorous compliance with medical record privacy and retention protocols.
How much funding has Oglethorpe Ear , Nose & Throat raised?
Oglethorpe Ear , Nose & Throat has raised a total of $83K across 1 funding round:
Debt
$83K
Debt (2021): $83K with participation from PPP
Key Investors in Oglethorpe Ear , Nose & Throat
PPP
Public-Private Partnership
What's next for Oglethorpe Ear , Nose & Throat?
The strategic roadmap for Oglethorpe Ear, Nose & Throat is currently centered on the orderly wind-down of new patient intake, scheduled for March 31, 2026, followed by the continued care of established patients until April 30, 2026. This capital infusion provides the necessary liquidity to support these administrative and clinical obligations during the transition. Looking ahead, the focus remains on the seamless transfer of medical records and the fulfillment of regulatory requirements, ensuring that the legacy of the practice is preserved while maintaining the highest standards of patient safety and data integrity throughout the final operational cycle.
See full Oglethorpe Ear , Nose & Throat company page
